Dark Forest Capital Management LP Pulmonx Corp Transaction History

Dark Forest Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $5,600 - $11,180	400 Added 210.53%	590 $9,000
Q1 2022 May 13, 2022	SELL	$21.13 - $35.65 $18,277 - $30,837	-865 Reduced 81.99%	190 $5,000
Q4 2021 Feb 11, 2022	SELL	$29.72 - $45.1 $287,659 - $436,522	-9,679 Reduced 90.17%	1,055 $34,000
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $386,209 - $477,448	10,734 New	10,734 $386,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.